Novel predictors of immune checkpoint inhibitor response and prognosis in advanced non‐small‐cell lung cancer with bone metastasis

BACKGROUNDS: Immune checkpoint inhibitors (ICIs) can significantly prolong the survival of patients with advanced non‐small‐cell lung cancer (NSCLC); however, few studies on the therapeutic effects of ICIs on bone metastases were performed. METHODS: This retrospective study aimed to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Asano, Yohei, Yamamoto, Norio, Demura, Satoru, Hayashi, Katsuhiro, Takeuchi, Akihiko, Kato, Satoshi, Miwa, Shinji, Igarashi, Kentaro, Higuchi, Takashi, Taniguchi, Yuta, Morinaga, Sei, Sone, Takashi, Okuda, Miho, Matsumoto, Isao, Yano, Seiji, Tsuchiya, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278505/
https://www.ncbi.nlm.nih.gov/pubmed/37076988
http://dx.doi.org/10.1002/cam4.5952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278505/
https://www.ncbi.nlm.nih.gov/pubmed/37076988
http://dx.doi.org/10.1002/cam4.5952

Ejemplares similares